Voluntary Informed Consent in Paediatric Oncology Research

In paediatric oncology, research and treatments are often closely combined, which may compromise voluntary informed consent of parents. We identified two key scenarios in which voluntary informed consent for paediatric oncology studies is potentially compromised due to the intertwinement of research...

Full description

Saved in:  
Bibliographic Details
Published in:Bioethics
Authors: Dekking, Sara A. S. (Author) ; Delden, Johannes J. M. van (Author) ; Graaf, Rieke Van Der (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Wiley-Blackwell [2016]
In: Bioethics
IxTheo Classification:NCH Medical ethics
Further subjects:B voluntariness
B Informed Consent
B children with cancer
B paediatric oncology
B research ethics
Online Access: Volltext (Verlag)
Volltext (doi)

MARC

LEADER 00000caa a22000002 4500
001 1727682947
003 DE-627
005 20210831153853.0
007 cr uuu---uuuuu
008 200824s2016 xx |||||o 00| ||eng c
024 7 |a 10.1111/bioe.12237  |2 doi 
035 |a (DE-627)1727682947 
035 |a (DE-599)KXP1727682947 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Dekking, Sara A. S.  |e VerfasserIn  |4 aut 
245 1 0 |a Voluntary Informed Consent in Paediatric Oncology Research 
264 1 |c [2016] 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a In paediatric oncology, research and treatments are often closely combined, which may compromise voluntary informed consent of parents. We identified two key scenarios in which voluntary informed consent for paediatric oncology studies is potentially compromised due to the intertwinement of research and care. The first scenario is inclusion by the treating paediatric oncologist, the second scenario concerns treatments confined to the research context. In this article we examine whether voluntary informed consent of parents for research is compromised in these two scenarios, and if so whether this is also morally problematic. For this, we employ the account of voluntary consent from Nelson and colleagues, who assert that voluntary consent requires substantial freedom from controlling influences. We argue that, in the absence of persuasion or manipulation, inclusion by the treating physician does not compromise voluntariness. However, it may function as a risk factor for controlling influence as it narrows the scope within which parents make decisions. Furthermore, physician appeal to reciprocity is not controlling as it constitutes persuasion. In addition, framing information is a form of informational manipulation and constitutes a controlling influence. In the second scenario, treatments confined to the research context qualify as controlling if the available options are restricted through manipulation of options. Although none of the influences is morally problematic in itself, a combination of influences may create morally problematic instances of involuntary informed consent. Therefore, safeguards should be implemented to establish an optimal environment for parents to provide voluntary informed consent in an integrated research-care context. 
650 4 |a children with cancer 
650 4 |a Informed Consent 
650 4 |a paediatric oncology 
650 4 |a research ethics 
650 4 |a voluntariness 
652 |a NCH 
700 1 |e VerfasserIn  |0 (DE-588)172600448  |0 (DE-627)69753524X  |0 (DE-576)133459888  |4 aut  |a Delden, Johannes J. M. van 
700 1 |a Graaf, Rieke Van Der  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Bioethics  |d Oxford [u.a.] : Wiley-Blackwell, 1987  |g 30(2016), 6, Seite 440-450  |h Online-Ressource  |w (DE-627)271596708  |w (DE-600)1480658-7  |w (DE-576)078707986  |x 1467-8519  |7 nnns 
773 1 8 |g volume:30  |g year:2016  |g number:6  |g pages:440-450 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12237  |x Verlag 
856 |u https://doi.org/10.1111/bioe.12237  |x doi  |3 Volltext 
936 u w |d 30  |j 2016  |e 6  |h 440-450 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 3742355414 
LOK |0 003 DE-627 
LOK |0 004 1727682947 
LOK |0 005 20210831153853 
LOK |0 008 200824||||||||||||||||ger||||||| 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixzo 
LOK |0 936ln  |0 1550736558  |a NCH 
ORI |a SA-MARC-ixtheoa001.raw